The tribunal stated that RRVL should have access to all necessary records and premises through RP Rajan Rawat to finalise the ...

The University of Sydney has been denied a request to raise its international student enrollment for the coming academic year ...

NCLT Cuttack held that application u/s. 33 of Insolvency and Bankruptcy Code for liquidation of Grid Steel and Alloys Limited ...

A major Russian attack on central Kyiv triggered a fire in a high-rise apartment building and targeted energy sites early on ...

A federal judge in Manhattan on Thursday (October 9) dismissed superstar rapper Drake’s defamation lawsuit over Kendrick ...

The firm voluntarily retracted the BLA amid an effort to reprioritize its pipeline and is looking for partners to advance the program.

The company said that the decision is based on business and strategic considerations and does not reflect concerns regarding ...

Rocket Pharmaceuticals withdraws FDA application for RP-L102 gene therapy, shifting focus to key programs. Read more here.

US late-stage biotech Rocket Pharmaceuticals today announced via a Securities Exchange filing that it has voluntarily withdrawn its Biologics License Application (BLA) to the US Food and Drug ...

Rocket has pulled an approval application to the FDA, with the biotech considering offloading the asset via external ...

FA is an inherited syndrome that impairs the body's chromosomal repair systems, causing the bone marrow to lose its ability ...

Rocket Pharmaceuticals said on Friday it has withdrawn its application for U.S. approval of its experimental gene therapy for a rare inherited blood disorder. The therapy RP-L102 was being tested in ...